John R. P. Tesser, MD

• B.S. – Yale University – New Haven, CI
• M.D. – University of Rochester School of Medicine and Dentistry – New York
• Residency in Internal Medicine – Maricopa Medical Center – Phoenix, AZ
• Fellowship in Rheumatology – Bowman Gray School of Medicine – Winston-Salem, NC
• Clinical Lecturer – University of Arizona Health Sciences Center
• Adjunct Assistant Professor of Medicine – Midwestern University – Phoenix, AZ
• Fellow of American College of Rheumatology
• Fellow of American College of Physicians
• Member of American Society of Bone and Mineral Research
• Member of International Society of Clinical Densitometry

Dr. Tesser is actively involved in performing multiple clinical research studies including all forms of rheumatic diseases with emphasis on rheumatoid and osteoarthritis and osteoporosis. He has been principal investigator on over 200 clinical research trials. He actively serves as a speaker and consultant for many groups, and he has published over 30 articles and abstracts in peer-reviewed medical journals, including the New England Journal of Medicine and Arthritis & Rheumatism.

AARA Locations: Glendale and Phoenix

Click here for directions to these locations

Although each of us came to the group from different backgrounds and experiences, we share a vision about how to deliver our services to those who need them in our community. It is centered on effectiveness and efficiency provided in a caring and civil environment. It was the challenges of diagnosing and customizing treatment to the individual that drew us to rheumatology. The evolution of our technology sustains the hope that we can make a difference every day to our patients.

Publications 

Solomon, D.H., Pincus, T., Shadick, N.A., Stratton, J., Ellrodt, J., Santacroce, L., Katz, J.N., Smolen, J.S. and (2021), Implementing Treat to Target (TTT) for Rheumatoid Arthritis (RA) During COVID: Results of a Virtual Learning Collaborative (LC) Program. Arthritis Care Res. Accepted Author Manuscript. https://doi.org/10.1002/acr.24830

 Ritchlin CT, Mease PJ, Boehncke W-H, et al. Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: pooled results through week 52 of two phase III, randomised, placebo-controlled studies. RMD Open 2022;8:e002195. doi:10.1136/ rmdopen-2022-002195

Tesser, J., Lin, I., Shiff, N.J. et al. Improvement in disease activity among patients with rheumatoid arthritis who switched from intravenous infliximab to intravenous golimumab in the ACR RISE registry. Clin Rheumatol (2022). https://doi.org/10.1007/s10067-022-06116-z 

Ellrodt J, Pincus, T, Shadick NA, Stratton J, Santacroce L, Katz JN, Smolen JS, Solomon DH, for the TRACTION Virtual Learning Collaborative*. Satisfaction With a Virtual Learning Collaborative Aimed at Implementing Treat to Target (TTT) In Rheumatoid Arthritis (RA). Journal of Clinical Rheumatology, in press.